Screening and identification of a novel target specific for hepatoma cell line HepG2 from the FliTrx bacterial peptide library

Acta Biochimica et Biophysica Sinica

Volumn 40, Issue 5, 2008, Pages 443-451

  Li, Wenhan ^a,b   Lei, Ping ^a   Yu, Bing ^a   Wu, Sha ^a   Peng, Jilin ^a   Zhao, Xiaoping ^a   Zhu, Huifen ^a   Kirschfink, Michael ^b   Shen, Guanxin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

3 D modeling; Bacterial display; Counter screening; FliTrx system; Hepatoma; Living cell panning; Tumor target

Indexed keywords

ESCHERICHIA COLI PROTEIN; PEPTIDE LIBRARY; THIOREDOXIN; TRXA PROTEIN, E COLI;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; HUMAN; LIVER CELL CARCINOMA; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; SEQUENCE ANALYSIS; TUMOR CELL LINE;

AMINO ACID SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; COMPUTER SIMULATION; DRUG DELIVERY SYSTEMS; DRUG DESIGN; ESCHERICHIA COLI PROTEINS; HUMANS; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; SEQUENCE ANALYSIS, PROTEIN; THIOREDOXINS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 43949092119     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2008.00412.x     Document Type: Article

References (33)

1. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004, 127 : S5 S16.
2. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Version 1.0. Lyon : IARC Press 2001.
3. El-Houseini ME, Mohammed SM, Wael ME, Tarek DH, Omar SD, Anwar AE. Enhanced detection of hepato-cellular carcinoma. Cancer Control 2005, 12 : 248 253.
4. Zhang B, Zhang Y, Wang J, Zhang Y, Chen J, Pan Y, Ren L et al. Screening and identification of a targeting peptide to hepatocarcinoma from a phage display peptide library. Mol Med 2007, 13 : 246 254.
5. Pan B, Li B, Russell SJ, Tom JY, Cochran AG, Fairbrother WJ. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor. J Mol Biol 2002, 316 : 769 787.
6. Sun LY, Chu TW, Wang Y, Wang XY. Radiolabeling and biodistribution of a nasopharyngeal carcinoma-targeting peptide identified by in vivo phage display. Acta Biochim Biophys Sin 2007, 39 : 624 632.
7. Lu Z, Murray KS, Van Cleave V, LaVallie ER, Stahl ML, McCoy JM. Expression of thioredoxin random peptide libraries on the Escherichia coli cell surface as functional fusions to flagellin: a system designed for exploring protein-protein interactions. Biotechnology 1995, 13 : 366 372.
8. Lu Z, LaVallie ER, McCoy JM. Using bio-panning of FLITRX peptide libraries displayed on E. coli cell surface to study protein-protein interactions. Methods Mol Biol 2003, 205 : 267 280.
9. Tripp BC, Lu Z, Bourque K, Sookdeo H, McCoy JM. Investigation of the "switch-epitope" concept with random peptide libraries displayed as thioredoxin loop fusions. Protein Eng 2001, 14 : 367 377.
10. Craik DJ, Simonsen S, Daly NL The cyclotides: novel macrocyclic peptides as scaffolds in drug design. Curr Opin Drug Discov Devel 2002, 251 260.
11. Li P, Roller PP. Cyclization strategies in peptide derived drug design. Curr Top Med Chem 2002, 2 : 325 341.
12. Ibrahim GF, Fleet GH, Lyons MJ, Walker RA. Method for the isolation of highly purified Salmonella flagellins. J Clin Microbiol 1985, 22 : 1040 1044.
13. Nilsson F, Tarli L, Viti F, Neri D. The use of phage display for the development of tumor targeting agents. Adv Drug Deliv Rev 2000, 43 : 165 196.
14. Bussolati B, Grange C, Tei L, Deregibus MC, Ercolani M, Aime S, Camussi G. Targeting of human renal tumor-derived endothelial cells with peptides obtained by phage display. J Mol Med 2007, 85 : 897 906.
15. Javitt NB. HepG2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J 1990, 4 : 161 168.
16. She YM, Narindrasorasak S, Yang S, Spitale N, Roberts EA, Sarkar B. Identification of metal-binding proteins in human hepatoma lines by immobilized metal affinity chromatography and mass spectrometry. Mol Cell Proteomics 2003, 2 : 1306 1318.
17. Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature 1996, 380 : 364 366.
18. Zurita AJ, Troncoso P, Cardó-Vila M, Logothetis CJ, Pasqualini R, Arap W. Combinatorial screenings in patients: the interleukin-11 receptor α as a candidate target in the progression of human prostate cancer. Cancer Res 2004, 64 : 435 439.
19. Rasmussen UB, Schreiber V, Schultz H, Mischler F, Schughart K. Tumor cell-targeting by phage-displayed peptides. Cancer Gene Ther 2002, 9 : 606 612.
20. Dane KY, Chan LA, Rice JJ, Daugherty PS. Isolation of cell specific peptide ligands using fluorescent bacterial display libraries. J Immunol Methods 2006, 309 : 120 129.
21. Ladner RC. Polypeptides from phage display. A superior source of in vivo imaging agents. Q J Nucl Med 1999, 43 : 119 124.
22. Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Bseiga J, Shao Y et al. Anti-Her2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin Cancer Res 2002, 8 : 1172 1181.
23. Zitzmann S, Krämer S, Mier W, Mahmut M, Fleig J, Altmann A, Eisenhut M et al. Identification of a new prostate-specific cyclic peptide with the bacterial FliTrx system. J Nucl Med 2005, 46 : 782 785.
24. Barry MA, Dower WJ, Johnston SA. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med 1996, 2 : 299 305.
25. Zhang J, Spring H, Schwab M. Neuroblastoma tumor cell-binding peptides identified through random peptide phage display. Cancer Lett 2001, 171 : 153 164.
26. Giordano RJ, Cardo-Vila M, Lahdenranta J, Pasqualini R, Arap W. Biopanning and rapid analysis of selective interactive ligands. Nat Med 2001, 7 : 1249 1253.
27. Romanov VI, Durand DB, Petrenko VA. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion. Prostate 2001, 47 : 239 251.
28. Binetruy-Tournaire R, Demangel C, Malavaud B, Vassy R, Rouyre S, Kraemer M. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J 2000, 19 : 1525 1533.
29. Folgori A, Tafi R, Meola A, Felici F, Galfré G, Cortese R, Monaci P et al. A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J 1994, 13 : 2236 2243.
30. Daugherty PS, Olsen MJ, Iverson BL, Georgiou G. Development of an optimized expression system for the screening of antibody libraries displayed on the Escherichia coli surface. Protein Eng 1999, 12 : 613 621.
31. Van Regenmortel MH. Antigenicity and immunogenicity of synthetic peptides. Biologicals 2001, 29 : 209 213.
32. Geysen HM, Mason TJ, Rodda SJ. Cognitive features of continuous antigenic determinants. J Mol Recognit 1988, 1 : 32 41.
33. Deshayes K, Schaffer ML, Skelton NJ, Nakamura GR, Kadkhodayan S, Sidhu SS. Rapid identification of small binding motifs with high-throughput phage display: discovery of peptidic antagonists of IGF-1 function. Chem Biol 2002, 9 : 495 505.